Respiratory Distress Syndrome
Conditions
Keywords
lung ultrasound
Brief summary
Lung Ultrasound (LUS) has been revealing an extremely useful tool to identify and monitor complications from Sars-COV-2 disease. Recently, a research group has proposed a score, named LUS Score, able to optimize the use of this diagnostic technique. LUS Score is computed analyzing chest posterior and lateral spaces, considering the number of artefacts generated by the inflammed interstitium (B lines), the characteristics of the pleural line and the presence or not of consolidation areas. The comparison between LUS and chest tomography (CT), the current gold standard for the diagnosis of interstitial pneumonia by COVID-19, has confirmed from the preliminary data, the reliability of such technique. Hence, the validation on a really large sample size of the ultrasound tool performed by dedicated personnel with high expertise, may allow the validation both in the clinical practice and in emergency and ordinary wards.
Interventions
DIAGNOSTIC_TESTlung ultrasound
the patients underwent to a non invasive diagnostic exam to identify and monitor clinical conditions and onset of respiratory complications due to COVID-19
Sponsors
University of Campania Luigi Vanvitelli
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No
Inclusion criteria
* men and women; * confirmed COVID19 diagnosis after nasal-oropharyngeal swab; * any symptom at hospitalization * any therapy * any pre-existing comorbidity
Exclusion criteria
* pregnant women * healthy subjects with other respiratory diseases different from COVID-19
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| validation of lung ultrasound score | 6 months | validation of lung ultrasound in the clinical practice of diagnosis of complications of low respiratory tracts during COVID-19 |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Association of LUS score with clinical outcome | 6 months | assessment of LUS score association with the clinical course of disease (final outcome, either discharged or in-hospital mortality |
| Association of LUS score with duration of hospitalization (days) | 6 months | assessment of LUS score association with hospitalization days |
| Association of LUS score with respiratory support required | 6 months | assessment of LUS score association with requirement of either sub-intensive or intensive therapy) |
Countries
Italy
Outcome results
None listed